Abstract
Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have become the gold standard for EGFR-mutated non-small cell lung ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
